Nationwide Rollout for Adolescent Girls
India Expands Preventive Shield with Free HPV Vaccination Drive: The Union Health Ministry has announced a nationwide HPV Vaccination Programme targeting 14-year-old girls. The vaccine will be voluntary and provided free of cost at government health facilities. The move aims to ensure equitable access across socio-economic groups.
The focus on girls aged 14 is strategic. Vaccination before potential exposure to the virus offers maximum preventive benefit. This approach aligns with global best practices for adolescent immunisation.
Static GK fact: India’s Universal Immunisation Programme (UIP) is one of the largest public health programmes in the world, covering millions of beneficiaries annually.
Use of Gardasil Vaccine
India will administer Gardasil Quadrivalent Vaccine, which protects against HPV types 16 and 18, responsible for the majority of cervical cancer cases. It also covers types 6 and 11, which cause genital warts.
Scientific evidence supports a single-dose schedule for the recommended age group. Studies show durable immunity and high effectiveness against vaccine-covered strains. Globally, more than 90 countries have adopted similar simplified schedules to increase coverage.
Static GK Tip: HPV vaccines are non-live vaccines, meaning they cannot cause infection.
Procurement and Quality Assurance
Vaccine supplies have been secured in partnership with Gavi Vaccine Alliance. This ensures adherence to international procurement standards and strict cold chain management.
The programme reflects India’s commitment to evidence-based immunisation policy. The National Technical Advisory Group on Immunisation (NTAGI) guides vaccine recommendations in the country.
Static GK fact: NTAGI functions under the Ministry of Health and Family Welfare and provides technical advice on immunisation policies.
Implementation Through Government Facilities
Vaccination will be conducted at designated public health centres, including Ayushman Arogya Mandirs, Primary Health Centres, Community Health Centres, Sub-District Hospitals, District Hospitals, and Government Medical Colleges.
Each vaccination session will be supervised by trained medical officers. Facilities will include post-vaccination observation protocols. All sites will be linked to 24×7 government health facilities to manage rare adverse events and ensure public confidence.
This integrated framework strengthens the safety architecture of the programme. It also enhances parental trust in preventive healthcare.
Addressing India’s Cervical Cancer Burden
Cervical cancer remains the second most common cancer among women in India. The country reports nearly 80,000 new cases and over 42,000 deaths annually. Persistent infection with high-risk HPV types, especially 16 and 18, accounts for more than 80% of cases.
Globally, over 500 million doses of HPV vaccines have been administered since 2006, establishing a strong safety record. Effectiveness ranges between 93–100% against vaccine-covered cancer-causing strains.
By focusing on early immunisation, India aims to reduce long-term morbidity and mortality. Preventive vaccination is more cost-effective than late-stage cancer treatment.
The initiative marks a decisive shift toward structured cancer prevention at the national level. It reinforces India’s broader objective of strengthening adolescent health and women’s healthcare outcomes.
Static Usthadian Current Affairs Table
India Expands Preventive Shield with Free HPV Vaccination Drive:
| Topic | Detail |
| Target Group | 14-year-old girls |
| Vaccine Used | Gardasil quadrivalent HPV vaccine |
| Key HPV Types Covered | 16, 18, 6 and 11 |
| Implementing Authority | Union Health Ministry |
| Advisory Body | National Technical Advisory Group on Immunisation |
| Procurement Partner | Gavi Vaccine Alliance |
| Major Disease Targeted | Cervical cancer |
| Annual Burden in India | Around 80,000 cases and 42,000 deaths |
